找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Extreme Hepatic Surgery and Other Strategies; Increasing Resectabi Eduardo de Santibañes,Victoria Ardiles,Martin de S Book 2017 Springer In

[复制链接]
查看: 52306|回复: 60
发表于 2025-3-21 19:13:51 | 显示全部楼层 |阅读模式
书目名称Extreme Hepatic Surgery and Other Strategies
副标题Increasing Resectabi
编辑Eduardo de Santibañes,Victoria Ardiles,Martin de S
视频video
概述Different strategies used to increase resectability in patients with colorectal liver metastases including tactics, technics, tips and tricks.The book shows that no patient is unresectable before gett
图书封面Titlebook: Extreme Hepatic Surgery and Other Strategies; Increasing Resectabi Eduardo de Santibañes,Victoria Ardiles,Martin de S Book 2017 Springer In
描述This book describes the diagnoses; staging and management of patients with colorectal liver metastases initially considered unresectable and portrays the different strategies to increase resectability along with their tactics and tricks. Colorectal carcinoma is the third most commonly diagnosed cancer in the world and according to recent cancer statistics around 1.23 million patients are diagnosed each year. Of these patients, approximately 50% will develop liver metastases during the course of their disease and around 15-25% are found to have stage IV disease at diagnosis. Liver resection has been recognized as the treatment of choice for these patients, offering overall 5-year survival rates of up to 50-60% and the only hope for cure. However, at diagnosis only 10-20% of these patients are possibly amenable to surgical resection with curative intent. The possibility to achieve an R0 resection is many times limited by the amount and quality of the future liver remnant (FLR), being posthepatectomy liver failure (PHLF) the most feared and severe complication after major liver resections. With the years, diverse strategies have been developed with the intention to increase resectabil
出版日期Book 2017
关键词ALPPS; Colorectal liver metastasis; Ex situ ressection; Liver oncology; Liver surgery; surgical oncology;
版次1
doihttps://doi.org/10.1007/978-3-319-13896-1
isbn_softcover978-3-319-79192-0
isbn_ebook978-3-319-13896-1
copyrightSpringer International Publishing Switzerland 2017
The information of publication is updating

书目名称Extreme Hepatic Surgery and Other Strategies影响因子(影响力)




书目名称Extreme Hepatic Surgery and Other Strategies影响因子(影响力)学科排名




书目名称Extreme Hepatic Surgery and Other Strategies网络公开度




书目名称Extreme Hepatic Surgery and Other Strategies网络公开度学科排名




书目名称Extreme Hepatic Surgery and Other Strategies被引频次




书目名称Extreme Hepatic Surgery and Other Strategies被引频次学科排名




书目名称Extreme Hepatic Surgery and Other Strategies年度引用




书目名称Extreme Hepatic Surgery and Other Strategies年度引用学科排名




书目名称Extreme Hepatic Surgery and Other Strategies读者反馈




书目名称Extreme Hepatic Surgery and Other Strategies读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 20:26:40 | 显示全部楼层
Endoscopic Sleeve Gastroplasty,an survival of 6–8 months in patients not receiving any treatment. The main treatment for CLM is surgical resection, although in about two-third of the patients, recurrence of the tumor occurs. The criteria for resectable CLM have been broadened over the past decades, leading to more CLM being consi
发表于 2025-3-22 02:16:04 | 显示全部楼层
The New UK Government Financial Framework the last decade, resulting in an increased rate of complex and extended liver resections. Postoperative outcomes mainly depend on the size and quality of the future liver remnant (FLR). Liver resection, when performed in the absence of sufficient FLR, inevitably leads to post-resectional liver fail
发表于 2025-3-22 05:26:24 | 显示全部楼层
发表于 2025-3-22 10:26:18 | 显示全部楼层
https://doi.org/10.1007/978-1-4939-0900-1therapeutic and adjunct techniques to surgery has contributed greatly to improve resectability rates and outcomes. As a consequence, patients with advanced CLM are living longer than they did previously due to these major advances in treatment. The surgical strategy should be tailored according to t
发表于 2025-3-22 15:53:48 | 显示全部楼层
发表于 2025-3-22 18:15:40 | 显示全部楼层
Halina Kwaśnicka,Lakhmi C. Jainficient future liver remnant (FLR). PVE is recommended when FLR <20% in normal liver, FLR <30% in liver pretreated with more than 3 months of chemotherapy, and FLR <40% in the cirrhotic liver. Embolization of the right or left portal vein branch causes atrophy of the ipsilateral liver and hypertroph
发表于 2025-3-22 23:55:00 | 显示全部楼层
发表于 2025-3-23 03:20:42 | 显示全部楼层
发表于 2025-3-23 06:37:26 | 显示全部楼层
Knowledge Engineering or Digital Humanities?make possible highly successful operations on patients who a few years ago would not have been considered for a hepatic resection surgery. Among the most important factors within modern anaesthesia care, we should specially mention three: (1) CVP (central venous pressure) goes down to diminish intro
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-12 07:42
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表